EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer

Kristene Myklak, Shandra Wilson

Prostate Cancer · 2011

DOI: 10.1155/2011/419174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostate Cancer, 2011. Verfasst von Kristene Myklak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, CO 80045, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quality of life has become increasingly more important for men diagnosed with prostate cancer. In light of this and the recognized risks of androgen deprivation therapy (ADT), the guidelines and use of ADT have changed significantly over the last few years. This paper reviews the current recommendations and the future perspectives regarding ADT. The benefits of ADT are evident neoadjuvantly and adjuvantly in patients treated with external beam radiation therapy for intermediate- and high-risk disease, in patients who have undergone prostatectomy with lymph node involvement, in high-risk patients after definitive therapy, and in patients who have developed progression or metastasis. Finally, this paper reviews the risks and benefits of each of these scenarios and the risks of androgen deprivation in general, and it delineates the areas where ADT was previously recommended, but where evidence is lacking for its additional benefit.

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, CO 80045, USA.

Zitieren

APA

Myklak, K., & Wilson, S. (2011). An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer. Prostate Cancer. https://doi.org/10.1155/2011/419174

Vancouver

Myklak K, Wilson S. An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer. Prostate Cancer. 2011. doi:10.1155/2011/419174

BibTeX
@article{Myklak2011,
  author = {Myklak, Kristene and Wilson, Shandra},
  title = {An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer},
  journal = {Prostate Cancer},
  year = {2011},
  doi = {10.1155/2011/419174}
}
Kostenlos starten →